State-of-the-art single-cell RNA sequencing and proteomics approaches were employed to benchmark porcine and human pancreatic ...
AbbVie has claimed its first regulatory approval, from the FDA, for its C-met-targeting antibody-drug conjugate (ADC) Emrelis as a treatment for a type of lung cancer. The US regulator cleared Emrelis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback